IP Library Granted Patent US 9,918,477
Granted Patent B2
US 9,918,477 · App. 14/893,448 · Granted Mar 20, 2018

Stabilized hypochlorous acid solution and use thereof

Inventor: Robert Northey (Bellevue, WA)
Assignee: Sonoma Pharmaceuticals, Inc.
A01N59/00A61K33/14A61K33/20A61K47/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,918,477
App. No.
14/893,448
Granted
Mar 20, 2018
Kind
B2
Abstract

Disclosed is an antimicrobial solution comprising, consisting essentially of or consisting of (a) hypochlorous acid, (b) a divalent cation, (c) phosphate anion, and (d) water, as well as a process for its production. Also disclosed is a method of treating or preventing infection associated with abdominal surgery on a mammal, comprising use of the antimicrobial solution.

Claims (26)

1. An antimicrobial solution, wherein the solution consists of:

(a) about 10 mg/L to about 500 mg/L of hypochlorous acid,

(b) magnesium sulfate in an amount sufficient to provide about 20 mg/L to about 250 mg/L of magnesium,

(c) sodium dihydrogen phosphate in an amount sufficient to provide about 200 mg/L to about 1000 mg/L of phosphate anion formulated as PO 4 2− ,

(d) chloride ion, and

(e) water,

wherein the solution has a pH of about 4.5 to about 5.5.

2. A process for the production of an antimicrobial solution comprising the steps of:

(i) providing a mixture consisting of (a) magnesium sulfate (b) sodium dihydrogen phosphate, (c) a pH-adjusting agent, and (d) water, and

(ii) adding chlorine gas to the mixture,

wherein the process produces a solution consisting of hypochlorous acid in an amount from about 10 mg/L to about 500 mg/L, magnesium sulfate in an amount sufficient to provide about 20 mg/L to about 250 mg/L of magnesium, sodium dihydrogen phosphate is present in an amount sufficient to provide about 200 mg/L to about 1000 mg/L of phosphate anion formulated as PO 4 2− , and chloride ion, and having a pH from about 3 to about 7.

3. The process of claim 2 , wherein hypochlorous acid is present in the solution in an amount from about 50 mg/L to about 250 mg/L.

4. The process of claim 2 , wherein chloride ion is present in the solution in an amount from about 20 mg/L to about 100 mg/L.

5. The process of claim 2 , wherein the chlorine gas is bubbled into the mixture.

6. A process for the production of an antimicrobial solution comprising the steps of:

(i) providing a mixture consisting of hypochlorous acid and water,

(ii) adding (a) magnesium sulfate, (b) sodium dihydrogen phosphate, and (c) a pH-adjusting agent to the mixture, and

(iii) adding chloride ion to the mixture,

wherein the process produces a solution consisting of hypochlorous acid in an amount from about 10 mg/L to about 500 mg/L, magnesium sulfate in an amount sufficient to provide about 20 mg/L to about 250 mg/L of magnesium, sodium dihydrogen phosphate is present in an amount sufficient to provide about 200 mg/L to about 1000 mg/L of phosphate anion formulated as PO 4 2− , and chloride ion, and having a pH from about 3 to about 7.

7. The process of claim 6 , wherein the hypochlorous acid is electrochemically generated.

8. The process of claim 6 , wherein hypochlorous acid is present in the solution in an amount from about 50 mg/L to about 250 mg/L.

9. The process of claim 6 , wherein chloride ion is present in the solution in an amount from about 20 mg/L to about 100 mg/L.

10. A method of treating or preventing infection associated with abdominal surgery on a mammal, comprising administering to the mammal an effective amount of the solution of claim 1 .

11. The method of claim 10 , wherein the surgery is inguinal hernia surgery, exploratory laparotomy, appendectomy, or laparoscopy.

12. The method of claim 10 , wherein the infection is caused by an organism selected from methicillin-resistant S. aureus, E. coli, P. aeruginosa , Vancomycin-resistant Enterococcus, P. mirabilis, S. marcescens , and C. albicans.

13. The solution of claim 1 , wherein chloride ion is present in the solution in an amount from about 20 mg/L to about 100 mg/L.

Assignments (2)
CHANGE OF NAME Recorded Jan 5, 2017
From: OCULUS INNOVATIVE SCIENCES, INC.
To: SONOMA PHARMACEUTICALS, INC.
Reel/Frame 041257/0375 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2015
From: NORTHEY, ROBERT
To: OCULUS INNOVATIVE SCIENCES, INC.
Reel/Frame 037135/0387 →
Continuity (2)
Provisional Application 61826382 · May 22, 2013
Related Publication 20160120183A1 · May 5, 2016